130 related articles for article (PubMed ID: 11908069)
1. Proteasome inhibitors.
Reboud-Ravaux M
Prog Mol Subcell Biol; 2002; 29():110-25. PubMed ID: 11908069
[No Abstract] [Full Text] [Related]
2. Components of the bovine pituitary multicatalytic proteinase complex (proteasome) cleaving bonds after hydrophobic residues.
Cardozo C; Michaud C; Orlowski M
Biochemistry; 1999 Jul; 38(30):9768-77. PubMed ID: 10423257
[TBL] [Abstract][Full Text] [Related]
3. Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design.
Furet P; Imbach P; Noorani M; Koeppler J; Laumen K; Lang M; Guagnano V; Fuerst P; Roesel J; Zimmermann J; García-Echeverría C
J Med Chem; 2004 Sep; 47(20):4810-3. PubMed ID: 15369383
[TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibitors and antigen presentation.
Bogyo M; Gaczynska M; Ploegh HL
Biopolymers; 1997; 43(4):269-80. PubMed ID: 9316392
[TBL] [Abstract][Full Text] [Related]
5. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme.
Ostrowska H; Wojcik C; Omura S; Worowski K
Biochem Biophys Res Commun; 1997 May; 234(3):729-32. PubMed ID: 9175783
[TBL] [Abstract][Full Text] [Related]
6. Global analysis of proteasomal substrate specificity using positional-scanning libraries of covalent inhibitors.
Nazif T; Bogyo M
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):2967-72. PubMed ID: 11248015
[TBL] [Abstract][Full Text] [Related]
7. Structural investigation of proteasome inhibition.
Ditzel L; Stock D; Löwe J
Biol Chem; 1997; 378(3-4):239-47. PubMed ID: 9165077
[TBL] [Abstract][Full Text] [Related]
8. The multicatalytic proteinase complex.
Rivett AJ
Revis Biol Celular; 1989; 20():113-23. PubMed ID: 2700095
[TBL] [Abstract][Full Text] [Related]
9. The proteasome system and proteasome inhibitors in stroke: controlling the inflammatory response.
Di Napoli M; Papa F
Curr Opin Investig Drugs; 2003 Nov; 4(11):1333-42. PubMed ID: 14758773
[TBL] [Abstract][Full Text] [Related]
10. The Leishmania mexicana proteasome.
Robertson CD
Mol Biochem Parasitol; 1999 Sep; 103(1):49-60. PubMed ID: 10514080
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibitors: complex tools for a complex enzyme.
Bogyo M; Wang EW
Curr Top Microbiol Immunol; 2002; 268():185-208. PubMed ID: 12083006
[TBL] [Abstract][Full Text] [Related]
12. Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits.
Kessler BM; Tortorella D; Altun M; Kisselev AF; Fiebiger E; Hekking BG; Ploegh HL; Overkleeft HS
Chem Biol; 2001 Sep; 8(9):913-29. PubMed ID: 11564559
[TBL] [Abstract][Full Text] [Related]
13. MLN-519. Millennium/PAION.
Di Napoli M; Papa F
Curr Opin Investig Drugs; 2003 Mar; 4(3):333-41. PubMed ID: 12735235
[TBL] [Abstract][Full Text] [Related]
14. Not just research tools--proteasome inhibitors offer therapeutic promise.
Goldberg AL; Rock K
Nat Med; 2002 Apr; 8(4):338-40. PubMed ID: 11927937
[No Abstract] [Full Text] [Related]
15. Arecoline tripeptide inhibitors of proteasome.
Marastoni M; Baldisserotto A; Canella A; Gavioli R; Risi CD; Pollini GP; Tomatis R
J Med Chem; 2004 Mar; 47(6):1587-90. PubMed ID: 14998343
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model.
Zollner TM; Podda M; Pien C; Elliott PJ; Kaufmann R; Boehncke WH
J Clin Invest; 2002 Mar; 109(5):671-9. PubMed ID: 11877475
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of bovine thymus multicatalytic proteinase complex.
Eleuteri AM; Angeletti M; Lupidi G; Tacconi R; Bini L; Fioretti E
Protein Expr Purif; 2000 Mar; 18(2):160-8. PubMed ID: 10686146
[TBL] [Abstract][Full Text] [Related]
18. Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells.
Cory AH; Cory JG
Anticancer Res; 2002; 22(6C):3805-9. PubMed ID: 12552998
[TBL] [Abstract][Full Text] [Related]
19. CD8+ T cell cross-priming via transfer of proteasome substrates.
Norbury CC; Basta S; Donohue KB; Tscharke DC; Princiotta MF; Berglund P; Gibbs J; Bennink JR; Yewdell JW
Science; 2004 May; 304(5675):1318-21. PubMed ID: 15166379
[TBL] [Abstract][Full Text] [Related]
20. A novel enantioselective synthetic route to omuralide analogues with the potential for species selectivity in proteasome inhibition.
Crane SN; Corey EJ
Org Lett; 2001 May; 3(9):1395-7. PubMed ID: 11348243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
